BusinessSarepta CEO welcomes Vertex’s effort to develop a competing muscular dystrophy drug By Jonathan Saltzman — Boston GlobeJune 8, 2019 Reprints Craig F. Walker/The Boston Globe Sarepta CEO says he welcomes Vertex’s effort to develop muscular dystrophy drugs About the Author Reprints Jonathan Saltzman — Boston Globe [email protected] Tags drug development
Biotech Bob Herman and Damian Garde STAT Plus: Moderna CEO made $398 million in 2022, but still pledges to give most to charity
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
Health Tech Brittany Trang and Casey Ross STAT Plus: ‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4 AI to its medical note-taking tool
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need